Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6605499rdf:typepubmed:Citationlld:pubmed
pubmed-article:6605499lifeskim:mentionsumls-concept:C0034650lld:lifeskim
pubmed-article:6605499lifeskim:mentionsumls-concept:C0037925lld:lifeskim
pubmed-article:6605499lifeskim:mentionsumls-concept:C0026056lld:lifeskim
pubmed-article:6605499lifeskim:mentionsumls-concept:C0441472lld:lifeskim
pubmed-article:6605499lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:6605499lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:6605499lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:6605499lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:6605499lifeskim:mentionsumls-concept:C0680242lld:lifeskim
pubmed-article:6605499lifeskim:mentionsumls-concept:C0073469lld:lifeskim
pubmed-article:6605499pubmed:issue2lld:pubmed
pubmed-article:6605499pubmed:dateCreated1983-12-17lld:pubmed
pubmed-article:6605499pubmed:abstractTextThe effect of midazolam, a new water-soluble benzodiazepine, on an in vitro slice preparation of the frog spinal cord was investigated using electrophysiological recordings. Midazolam potently (ED50 = 1 nM) enhanced the depolarizing action of GABA on primary afferent fibres while leaving the depolarizing effect of glutamate, glycine or high K+ solutions unchanged. Concentrations of midazolam higher than 100 nM had an antagonistic effect on GABA responses. Ro 14-7437 was a powerful and selective antagonist of the midazolam potentiation without affecting control responses to GABA, glutamate or high K+. The antagonism of GABA responses induced by high doses of midazolam was not sensitive to Ro 14-7437. Our data suggest that midazolam is a very potent and selective modulator of GABA responses: this finding illustrates that electrophysiological techniques can detect specific effects of very low concentrations of benzodiazepines on a CNS slice preparation with well preserved architectural organization.lld:pubmed
pubmed-article:6605499pubmed:languageenglld:pubmed
pubmed-article:6605499pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6605499pubmed:citationSubsetIMlld:pubmed
pubmed-article:6605499pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6605499pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6605499pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6605499pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6605499pubmed:statusMEDLINElld:pubmed
pubmed-article:6605499pubmed:monthAuglld:pubmed
pubmed-article:6605499pubmed:issn0304-3940lld:pubmed
pubmed-article:6605499pubmed:authorpubmed-author:NistriAAlld:pubmed
pubmed-article:6605499pubmed:authorpubmed-author:BertzRRlld:pubmed
pubmed-article:6605499pubmed:issnTypePrintlld:pubmed
pubmed-article:6605499pubmed:day29lld:pubmed
pubmed-article:6605499pubmed:volume39lld:pubmed
pubmed-article:6605499pubmed:ownerNLMlld:pubmed
pubmed-article:6605499pubmed:authorsCompleteYlld:pubmed
pubmed-article:6605499pubmed:pagination199-204lld:pubmed
pubmed-article:6605499pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:6605499pubmed:meshHeadingpubmed-meshheading:6605499-...lld:pubmed
pubmed-article:6605499pubmed:meshHeadingpubmed-meshheading:6605499-...lld:pubmed
pubmed-article:6605499pubmed:meshHeadingpubmed-meshheading:6605499-...lld:pubmed
pubmed-article:6605499pubmed:meshHeadingpubmed-meshheading:6605499-...lld:pubmed
pubmed-article:6605499pubmed:meshHeadingpubmed-meshheading:6605499-...lld:pubmed
pubmed-article:6605499pubmed:meshHeadingpubmed-meshheading:6605499-...lld:pubmed
pubmed-article:6605499pubmed:meshHeadingpubmed-meshheading:6605499-...lld:pubmed
pubmed-article:6605499pubmed:meshHeadingpubmed-meshheading:6605499-...lld:pubmed
pubmed-article:6605499pubmed:meshHeadingpubmed-meshheading:6605499-...lld:pubmed
pubmed-article:6605499pubmed:meshHeadingpubmed-meshheading:6605499-...lld:pubmed
pubmed-article:6605499pubmed:year1983lld:pubmed
pubmed-article:6605499pubmed:articleTitlePotentiating action of midazolam on GABA-mediated responses and its antagonism by Ro 14-7437 in the frog spinal cord.lld:pubmed
pubmed-article:6605499pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6605499pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:6605499pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6605499lld:pubmed